help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, D. C.
Right arrow Articles by Davidson, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, D. C.
Right arrow Articles by Davidson, M. B.

Journal of Clinical Endocrinology & Metabolism, Vol 60, 1038-1041, Copyright © 1985 by Endocrine Society


ARTICLES

Hyperthyroid Graves' disease causes insulin antagonism

DC Shen and MB Davidson

Oral glucose tolerance and pancreatic suppression tests were carried out in six young hyperthyroid men before treatment and 2-4 weeks after thyroid function tests returned to normal and in six normal men matched for age and weight. Glucose intolerance was present in the hyperthyroid individuals. It improved, but did not return to normal, after treatment. Insulin secretion was increased, and the peak values were delayed in the patients. Treatment did not influence the amount or pattern of the insulin response. Steady state plasma glucose levels (milligrams per dl +/- SEM) were significantly (P less than 0.001) higher in the hyperthyroid patients before treatment (128.6 +/- 2.4) than in the normal subjects (86.1 +/- 3.1). Although after treatment, steady state plasma glucose levels (116.1 +/- 2.7) decreased significantly (P less than 0.001), they remained higher than those in normal subjects (P less than 0.01). Therefore, insulin action was impaired in hyperthyroidism and had not returned to normal by 2-4 weeks after thyroid function tests were in the normal range.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, E. Koukkou, D. Panagiotakos, N. Tountas, T. Economopoulos, and S. A. Raptis
Insulin-Stimulated Rates of Glucose Uptake in Muscle in Hyperthyroidism: The Importance of Blood Flow
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2413 - 2415.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. Ortega, J. Koska, N. Pannacciulli, J. C Bunt, and J. Krakoff
Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals
Eur. J. Endocrinol., February 1, 2008; 158(2): 217 - 221.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society